X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
to2 (99) 99
index medicus (93) 93
humans (91) 91
oncology (90) 90
original reports (75) 75
female (64) 64
middle aged (55) 55
aged (50) 50
male (48) 48
adult (34) 34
treatment outcome (33) 33
prognosis (30) 30
disease-free survival (23) 23
antineoplastic combined chemotherapy protocols - therapeutic use (22) 22
aged, 80 and over (17) 17
mutation (17) 17
neoplasm staging (17) 17
to4 (17) 17
bios4 (16) 16
bc8 (15) 15
risk factors (15) 15
survival analysis (15) 15
bios3 (14) 14
expression (14) 14
to14 (14) 14
chemotherapy (13) 13
proportional hazards models (13) 13
risk assessment (13) 13
survival (13) 13
breast neoplasms - drug therapy (12) 12
disease progression (12) 12
immunohistochemistry (12) 12
predictive value of tests (12) 12
chemotherapy, adjuvant (10) 10
time factors (10) 10
to15 (10) 10
biomarkers, tumor - analysis (9) 9
breast neoplasms - pathology (9) 9
breast-cancer (9) 9
colorectal-cancer (9) 9
kaplan-meier estimate (9) 9
prospective studies (9) 9
thor12 (9) 9
to20 (9) 9
to5 (9) 9
young adult (9) 9
adolescent (8) 8
antineoplastic agents - therapeutic use (8) 8
bc2 (8) 8
gene expression profiling (8) 8
genetic predisposition to disease (8) 8
neoplasms - drug therapy (8) 8
randomized controlled trials as topic (8) 8
retrospective studies (8) 8
to11 (8) 8
biomarkers, tumor - blood (7) 7
breast neoplasms - chemistry (7) 7
cancer (7) 7
cell lung-cancer (7) 7
cohort studies (7) 7
gene expression regulation, neoplastic (7) 7
gic7 (7) 7
lung neoplasms - drug therapy (7) 7
lung neoplasms - pathology (7) 7
proto-oncogene proteins b-raf - genetics (7) 7
quinazolines - administration & dosage (7) 7
reproducibility of results (7) 7
to8 (7) 7
activation (6) 6
animals (6) 6
bc5 (6) 6
bevacizumab (6) 6
biomarkers, tumor - genetics (6) 6
biomarkers, tumor - metabolism (6) 6
biopsy (6) 6
breast neoplasms - genetics (6) 6
breast neoplasms - mortality (6) 6
cells (6) 6
gene (6) 6
hema9 (6) 6
lung neoplasms - blood (6) 6
lung neoplasms - genetics (6) 6
neoplasms - genetics (6) 6
to19 (6) 6
tumors (6) 6
antineoplastic combined chemotherapy protocols - adverse effects (5) 5
bc7 (5) 5
carcinoma (5) 5
carcinoma, non-small-cell lung - drug therapy (5) 5
class i phosphatidylinositol 3-kinases (5) 5
faze (5) 5
gene amplification (5) 5
growth-factor receptor (5) 5
neoplasms - pathology (5) 5
neur8 (5) 5
phenotype (5) 5
phosphatidylinositol 3-kinases - genetics (5) 5
prostatic neoplasms - pathology (5) 5
receptors, estrogen - analysis (5) 5
risk (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 2014, Volume 32, Issue 11, pp. 1136 - 1142
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 08/2012, Volume 30, Issue 24, pp. 2956 - 2962
Purpose To compare the mutational and copy number profiles of primary and metastatic colorectal carcinomas (CRCs) using both unpaired and paired samples... 
CANCER PATIENTS | KRAS MUTATIONS | PANITUMUMAB | K-RAS MUTATIONS | CETUXIMAB | ACTIVATION | ONCOLOGY | RECTUM | BRAF | COLON | TUMORS | Genes, p53 | Proto-Oncogene Proteins B-raf - genetics | Colorectal Neoplasms - genetics | Humans | Colorectal Neoplasms - secondary | Female | Male | Gene Expression Profiling | Mutation | DNA Copy Number Variations | Index Medicus | To15 | Original Reports | To7 | To2 | Gic7
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 06/2015, Volume 33, Issue 17, pp. 1902 - 1909
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 11/2013, Volume 31, Issue 32, pp. 4105 - 4114
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 2014, Volume 32, Issue 8, pp. 768 - 773
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 08/2009, Volume 27, Issue 24, pp. 4027 - 4034
Purpose Biomarkers can add substantial value to current medical practice by providing an integrated approach to prediction using the genetic makeup of the... 
CELL LUNG-CANCER | POSITIVE BREAST-CANCER | ADJUVANT CHEMOTHERAPY | GROWTH-FACTOR RECEPTOR | SURVIVAL BENEFIT | ONCOLOGY | COLORECTAL-CANCER | PHASE-III | MINDACT TRIAL | GENE COPY NUMBER | GEFITINIB IRESSA | Clinical Trials as Topic | Retrospective Studies | Prospective Studies | Biomarkers, Tumor | Research Design | Humans | Index Medicus | To2 | Bios3 | Statistics in Oncology
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2010, Volume 28, Issue 15, pp. 2493 - 2498
Purpose We previously reported that a panel of four kallikrein forms in blood-total, free, and intact prostate-specific antigen (PSA) and kallikrein-related... 
ANTIBODIES | MORTALITY | ASSAY | ONCOLOGY | MEN | PATTERNS | LEVEL | ANTIGEN | PSA | Prostatic Neoplasms - pathology | Early Detection of Cancer - methods | Biopsy | Humans | Middle Aged | Prostatic Neoplasms - blood | Male | Aged | Kallikreins - blood | Prostate-Specific Antigen - blood | Cohort Studies | Index Medicus | Original Reports | To2 | Guc2
Journal Article